Related Experiment Video
Updated: May 13, 2026
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
The cost of materials for intra-arterial thrombectomy
1Department of Interventional Radiology, University Hospital of Strasbourg, NHC, Strasbourg, France. fabricebing@yahoo.fr
Insights
The cost of endovascular materials for large-vessel ischemic stroke treatment was €5018. Evaluating the long-term economic impact of these new technologies is crucial for healthcare systems.
Area of Science:
- Neurology
- Interventional Cardiology
- Health Economics
Background:
- Large-vessel ischemic stroke in the anterior circulation requires timely intervention.
- Endovascular treatment has emerged as a key therapeutic option.
- Understanding the associated material costs is vital for healthcare planning.
Purpose of the Study:
- To determine the cost of endovascular materials used in treating anterior circulation large-vessel ischemic stroke.
- To correlate material costs with angiographic and clinical outcomes at three months.
Main Methods:
- Retrospective analysis of 57 ischemic stroke patients treated between November 2009 and July 2011.
- Patient selection using non-enhanced CT scans.
- Assessment of recanalization via Thrombolysis In Myocardial Infarction (TIMI) score and modified Rankin Scale (mRS) at three months.
Main Results:
- Complete or partial recanalization (TIMI grade 2 or 3) was achieved in 82.5% of patients.
- 33.3% of patients achieved a modified Rankin score ≤ 2 at three months.
- The mean cost of materials used in the operating room was €5018 ± €2402.
Conclusions:
- Intra-arterial thrombolysis for ischemic stroke involves substantial initial material costs.
- The long-term economic impact and cost-effectiveness of these technologies require thorough evaluation.
- Healthcare systems must consider these costs in future treatment decisions and prioritize randomized controlled trials.
Abstract:
This paper reports the cost of endovascular materials used for the treatment of large-vessel ischemic stroke in the anterior circulation according to the angiographic score and clinical results at three months. From November 2009 to July 2011, 57 ischemic patients (mean age, 64.6 ±13.8 years) with anterior large vessel occlusion were included. Mean National Institutes of Health Stroke Scale (NIHSS) on admission was 18.4 ± 4.9. Mean duration of symptoms until the arterial puncture was 207±67 minutes. Recanalization was assessed using the Thrombolysis In Myocardial Infarction (TIMI) score. Patient selection was performed on a non-enhanced CT scanner. According to the TIMI final angiographic score and the modified Rankin score (mRS) at three months, we determined the cost of the material used. Complete (n=12, TIMI grade 3) or partial perfusion (n=35, TIMI grade 2) was achieved in 47 (82.5%) lesions. At three months, 33.3% (n=19) had a mRS score ≤ 2. The mean cost of the material used in the operative room was 5018±2402 euro. Intra-arterial thrombolysis presents a substantial initial cost and the long-term economic impact has to be evaluated. Our health system has to take the price of these new technologies into account for future medical choices and urgently evaluate them in randomized controlled trials.
